| | | | | |
| $31,8450 | -0,02 % | $280,50M | $1,38K | |
DBL DOUBLELINE OPPORTUNISTIC CREDIT FUND | $14,0600 | +0,00 % | $280,16M | $46,75K | |
TSI TCW Strategic Income Fund, Inc. | $4,3800 | +0,00 % | $279,70M | $255,73K | |
PAII Pyrophyte Acquisition Corp. II | $10,2700 | +0,00 % | $279,21M | $18,11K | |
| $14,0300 | +0,21 % | $279,07M | $3,55K | |
YDES YD Bio Limited Ordinary Shares | $4,6500 | -0,22 % | $279,07M | $4,000 | |
XCBE X3 Acquisition Corp. Ltd. Class A Ordinary Shares | $9,9900 | +0,00 % | $278,71M | $28,00 | |
RWAY Runway Growth Finance Corp. Common Stock | $6,5700 | +0,00 % | $278,70M | $1,27K | |
JILL J.Jill, Inc. Common Stock | $20,0100 | +0,00 % | $278,69M | $34,63K | |
LCTX Lineage Cell Therapeutics, Inc. | $1,0899 | -0,01 % | $278,19M | $599,00 | |
AXIN Axiom Intelligence Acquisition Corp 1 Class A Ordinary Shares | $10,3150 | -0,05 % | $278,12M | $14,63K | |
ACV Virtus Diversified Income & Convertible Fund | $26,4600 | +0,00 % | $278,09M | $9,83K | |
ALXO ALX Oncology Holdings Inc. Common Stock | $1,9850 | -0,25 % | $277,93M | $243,23K | |
| $1,4100 | +0,71 % | $277,83M | $2,000 | |
YSG Yatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares | $3,2000 | +6,67 % | $277,66M | $1,000 | |
